FDA Inspection 1230774 — OpAns, LLC
The FDA completed an inspection of OpAns, LLC on January 24, 2024 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 24, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Durham, NC (United States)
Additional Details
Bioanalytical BA/BE